Pharma Stocks Rally! Nifty Pharma hits 52-week high, gains 27% in 2026, outperforms Nifty 50 - What's driving rally?
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓The Nifty Pharma index hit a fresh 52-week high on Monday, November 9, after several companies reported their September-quarter earnings.
- ✓Shares of Gland Pharma, Sai Life Sciences, Glenmark Pharmaceuticals and Divi's Laboratories got a boost, rising up to 6.61 per cent.
- ✓Many firms showed healthy growth in their recent results.
Story at a Glance
- Category
- Indian Markets
- Reported By
- Zee Business
- Reading Speed
- 6 Minute(s)
- Market Focus
- India Economy
Shares of Gland Pharma, Sai Life Sciences, Glenmark Pharmaceuticals and Divi's Laboratories were among the top gainers, rising to 6.61 per cent during the session.
Pharmaceutical stocks rallied on Monday, November 9, with the Nifty Pharma index hitting a fresh 52-week high after several companies reported their September-quarter earnings.
Shares of Gland Pharma, Sai Life Sciences, Glenmark Pharmaceuticals and Divi's Laboratories were among the top gainers, rising up to 6.61 per cent during the session.
The Nifty Pharma index was trading at 28,822.80, up 395.05 points, or 1.39 per cent. The index crossed its previous 52-week high of 28,494.50 and touched a new peak, while its 52-week low stands at 21,149.90.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Zee Business
Read the full, original unfiltered story directly on the publisher's portal.
This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.